Rolapitant
Back to searchMolecule Structure
Scientific Name
Rolapitant
Description of the Drug
Rolapitant is a neurokinin-1 (NK-1) receptor antagonist used in combination with other antiemetics for the prevention of delayed nausea and vomiting associated with emetogenic chemotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09291
http://www.drugbank.ca/drugs/DB09291
Brand Name(s)
Varuby
Company Owner(s)
Tersera Therapeutics Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Neurokinin 1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL249 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL354305 | ||
DrugBank | DB09291 | ||
PubChem: Thomson Pharma | 15319052 | ||
PubChem | 10311306 | ||
EPA CompTox Dashboard | DTXSID90203740 | ||
DrugCentral | 5027 | ||
ChemicalBook | CB12628366 | ||
Guide to Pharmacology | 5749 | ||
rxnorm | ROLAPITANT HYDROCHLORIDE | ROLAPITANT | VARUBI |
ChEBI | 90908 | ||
ZINC | ZINC000003816514 |